(Q47592773)

English

Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.

scientific article published in August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease. (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

Alzheimer's disease

0 references

0 references

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

frontotemporal dementia

1 reference

based on heuristic

inferred from title

frontotemporal lobar degeneration

1 reference

based on heuristic

inferred from title

parkinsonian syndrome

1 reference

based on heuristic

inferred from title

Glenda Halliday

20

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

Dennis W. Dickson

24

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

Stuart Pickering-Brown

27

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

Zbigniew K Wszolek

25

object named as

Z Wszolek

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

7

object named as

E H Bigio

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

author name string

A-M Shiarli

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

R Jennings

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

J Shi

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

K Bailey

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

Y Davidson

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

J Tian

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

B Ghetti

8

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

J R Murrell

9

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

M B Delisle

10

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

S Mirra

11

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

B Crain

12

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

P Zolo

13

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

K Arima

14

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

E Iseki

15

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

S Murayama

16

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

H Kretzschmar

17

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

M Neumann

18

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

C Lippa

19

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

J Mackenzie

21

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

N Khan

22

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

R Ravid

23

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

T Iwatsubo

26

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

D M A Mann

28

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

publication date

1 August 2006

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

Neuropathology and Applied Neurobiology

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

32

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

374-387

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Tau is a candidate gene for chromosome 17 frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Medical and environmental risk factors for sporadic frontotemporal dementia: a retrospective case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Phenotypic correlations in FTDP-17.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Pick's disease is associated with mutations in the tau gene.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Tau gene mutation K257T causes a tauopathy similar to Pick's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Pick's disease associated with the novel Tau gene mutation K369I.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Phenotypic variation in hereditary frontotemporal dementia with tau mutations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Tau gene mutation in familial progressive subcortical gliosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

The evolution and pathology of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Amyloid beta protein deposition in patients with frontotemporal lobar degeneration: relationship to age and apolipoprotein E genotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

The carboxyl third of tau is tightly bound to paired helical filaments.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Human GAP-43: its deduced amino acid sequence and chromosomal localization in mouse and human

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Promotion of hyperphosphorylation by frontotemporal dementia tau mutations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Tau pathology in Alzheimer disease and other tauopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Pick's disease. A clinical, computed tomographic, and histologic study with golgi impregnation observations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00736.X

21 January 2018

Identifiers

10.1111/J.1365-2990.2006.00736.X

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16866983

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47592773&oldid=2062021323"